Key takeaway: Religare Enterprises Limited's investor presentation for the earnings call scheduled on August 13, 2026, provided an overview of the company's operational and financial performance for the quarter ended June 30, 2026. The presentation highlighted a consolidated revenue of Rs. 2,358.4 crore, marking a 26% year-over-year growth, while the profit after tax was reported as a loss of Rs. 46.9 crore. The company noted a significant increase in cash and cash equivalents, which grew by 170% year-over-year to Rs. 378.3 crore. The presentation also detailed the performance of its subsidiaries, including Care Health Insurance, which achieved a gross written premium of Rs. 3,247 crore, reflecting a 37% year-over-year growth. Management emphasized the importance of strong corporate governance and leadership appointments aimed at driving future growth.

Key takeaway: Religare Enterprises Limited held its earnings conference call on May 13, 2026, to discuss its operational and financial performance for the quarter and year ended March 31, 2026. Management reported significant progress in leadership and governance, including the reconstitution of the Board and the appointment of new directors. The company highlighted a total income of INR 8,493 crores for FY '26, with a reported profit after tax of INR 73.16 crores. Key subsidiaries, including Care Health Insurance, reported strong growth, with gross written premiums of INR 11,417 crores. The company announced a proposed demerger to create two focused entities, separating its financial services from health insurance. Management emphasized a commitment to building a scalable and sustainable business, with ongoing efforts to streamline operations and enhance capital availability. The call concluded with a Q&A session addressing shareholder concerns regarding the demerger and future growth strategies.

Key takeaway: Religare Enterprises Limited's investor presentation detailed the company's operational and financial performance for the quarter and year ended March 31, 2026. The presentation highlighted a consolidated revenue of approximately Rs. 2,473 crore for Q4 FY26 and a profit after tax (PAT) of around Rs. 96 crore. The health insurance segment, Care Health Insurance Limited, reported a Gross Written Premium (GWP) of approximately Rs. 3,511 crore, reflecting a 29% quarter-on-quarter growth. The financial services segment, Religare Finvest Limited, achieved a PAT of Rs. 89 crore, with a capital adequacy ratio (CRAR) of 261.9%. The presentation also noted a capital raise of Rs. 1,500 crore through a preferential issue and the demerger of the financial services business to enhance focus on distinct segments. Key leadership appointments were made to strengthen governance and operational capabilities across the group.

Key takeaway: Religare Enterprises Limited held its Q3 FY '26 earnings conference call on February 16, 2026, to discuss its operational and financial performance. Management provided an overview of the company's diversified financial services, including Care Health Insurance, Religare Broking, Religare Finvest, and Religare Housing Finance. The earnings report indicated a total income of INR 2,067.9 crores for the quarter, up from INR 1,670.2 crores year-on-year, while total expenses were INR 2,171 crores, resulting in a negative profit before tax of INR 103.1 crores. Management highlighted a mixed operating environment but noted stable core performance, supported by a strong capital position. The call also addressed the proposed demerger of financial services and insurance businesses into two independent entities, aimed at unlocking shareholder value and enhancing operational focus. The management emphasized ongoing governance improvements and leadership strengthening across the group.

Key takeaway: Religare Enterprises Limited's investor presentation, dated February 15, 2026, outlines the company's operational and financial performance for the quarter and year-to-date ending December 31, 2025. The presentation highlights the diverse business segments, including Care Health Insurance, Religare Broking, Religare Finvest, and Religare Housing Development Finance Corporation. Key financial metrics indicate a total income of Rs. 2,067.9 crore for Q3 FY26, up from Rs. 1,670.2 crore in Q3 FY25, although the company reported a net loss of Rs. 76.5 crore for the period. The document also discusses the ongoing reorganization of the financial services business, aiming to create a focused entity for better investor attraction and operational efficiency. Management emphasized the importance of governance and compliance in driving future growth.